Lightnews — Scholar-powered news

Ben Mullish @bhmullish.bsky.social · 27d

Honoured to speak on #FMT #LBPs at the #EHMSG meeting today in session with Nicolas Benech and Jens Walter. Thanks to Gianluca Ianiro for organising, and for even getting a @nobelprize.bsky.social winner for Physics to speak to us, Giorgio Parisi! @imperialmdr.bsky.social #microbiomeclinicians

2 2 6

Reposted by Ben Mullish

Mark Gilchrist @mgilchrist123.bsky.social · Aug 10

www.sciencedirect.com/science/arti... - we used an AMS approach to operationalise & formalise a structured approach to FMT @imperialcollegeldn.bsky.social @imperialnhs.bsky.social

Operational considerations for the running of an NHS faecal microbiota transplant (FMT) service

www.sciencedirect.com

1 1 1

Ben Mullish @bhmullish.bsky.social · Aug 10

Out now from us in @thejhi.bsky.social - operational considerations in running an #NHS #FMT service: www.sciencedirect.com/science/arti... @imperialmdr.bsky.social @imperialbrc.bsky.social #GastroSky #MicroSky #IDSky

Operational considerations for the running of an NHS faecal microbiota transplant (FMT) service

www.sciencedirect.com

3 2

Ben Mullish @bhmullish.bsky.social · Jul 29

Very pleased to see this out in @cmijournal.bsky.social - what non-antimicrobial options are there for recurrent #UTI, and what might be the role for #FMT? www.clinicalmicrobiologyandinfection.com/article/S119... @rohmaghani.bsky.social @imperialmdr.bsky.social @imperialbrc.bsky.social #MicroSky

https://clinicalmicrobiologyandinfection.com/article/S1198-…

2 5

Reposted by Ben Mullish

Julie A. K. McDonald @julieakmcdonald.bsky.social · Jul 22

We’ve also written a Behind the Paper blog post to accompany our article, which you can find here: go.nature.com/401ctsa

Antibiotics fuel the rise of vancomycin-resistant enterococci intestinal colonisation by remodelling the metabolic landscape of the gut microbiome

Antibiotics save lives- but also reshape the gut microbiome, unintentionally promoting VRE colonisation. This study reveals how antibiotic-driven metabolic shifts promote VRE expansion and highlights ...

go.nature.com

2 4

Ben Mullish @bhmullish.bsky.social · Jul 18

Great to see this work from Shiv Radhakrishnan and colleagues out in #GutMicrobes - using network analysis to explore #microbiome #metabolome interactions in an #IBD inception cohort: doi.org/10.1080/1949... @imperialmdr.bsky.social @imperialhepatology.bsky.social #IBDSky #GISky

doi.org

2 2

Reposted by Ben Mullish

Julie A. K. McDonald @julieakmcdonald.bsky.social · Jul 14

So excited to share a new paper from my lab just published in Nature Communications! We showed that vancomycin-resistant enterococci (VRE) occupied distinct intestinal niches in the antibiotic-treated intestine. doi.org/10.1038/s414... Amazing work by first author Olivia King and colleagues!

Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation - Nature Communications

Here, the authors show that vancomycin-resistant enterococci grow in the antibiotic-treated gut microbiome by utilising enriched nutrients in the presence of reduced concentrations of inhibitory micro...

doi.org

3 13 38

Reposted by Ben Mullish

ᐯIᑕTOᖇ ᑎIᘔET, ᗰᗪ @nizet.bsky.social · Jul 11

Vancomycin-resistant 𝙀𝙣𝙩𝙚𝙧𝙤𝙘𝙤𝙘𝙘𝙪𝙨 𝙛𝙖𝙚𝙘𝙞𝙪𝙢 (VRE) thrives in the antibiotic-perturbed gut

VRE gobbles up enriched sugars and amino acids, and loss of short-chain fatty acids (acetate, propionate, butyrate) eliminates natural growth brakes

Therapeutic angle: Prebiotic SCFA mixtures block VRE growth!

Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation - Nature Communications

Here, the authors show that vancomycin-resistant enterococci grow in the antibiotic-treated gut microbiome by utilising enriched nutrients in the presence of reduced concentrations of inhibitory micro...

www.nature.com

1 9 27

Ben Mullish @bhmullish.bsky.social · Jul 10

A great privilege to work with @julieakmcdonald.bsky.social lab on this new paper, now out in @natureportfolio.nature.com Communications - how #antibiotic-related changes in gut #nutrients and #metabolites promote #VRE colonisation: doi.org/10.1038/s414... @imperialmdr.bsky.social

https://doi.org/10.1038/s41467…

3 7

Ben Mullish @bhmullish.bsky.social · May 10

And keeping an open mind about other therapeutic strategies, including vancomycin - read more about work by @nabilquraishi.bsky.social and colleagues on this here: bsky.app/profile/bhmu...

Ben Mullish @bhmullish.bsky.social · Dec 14

Great work by Nabil Quraishi, Palak Trivedi and many others - unravelling the positive impact of #vancomycin in #PSC #IBD by altering interactions between the host, #microbiome, and #metabolome. Now in #JCC: academic.oup.com/ecco-jcc/adv... #GastroSky

Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures

AbstractBackground. We conducted a single-arm interventional study, to explore mucosal changes associated with clinical remission under oral vancomycin (OV

academic.oup.com

Ben Mullish @bhmullish.bsky.social · May 10

Well - for one - looking forward to the results of the FARGO trial @cholestasisdoc.bsky.social @pscsupport.bsky.social: bsky.app/profile/bhmu...

Ben Mullish @bhmullish.bsky.social · Jan 7

Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social

FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial

Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...

doi.org

1 1

Ben Mullish @bhmullish.bsky.social · May 10

Honoured to to be part of this Future of Hepatology session at @easlnews.bsky.social #EASL2025, discussing the promise of #microbiome related therapies in #PSC #cholestatic liver disease - where have we come since the original #FMT #PSC pilot study by @DrAllegrettiIBD? doi.org/10.14309/ajg...

2 3 8

Reposted by Ben Mullish

MAST Study @mast-study.bsky.social · Mar 28

Delighted to welcome Manchester Royal Infirmary onto the #MAST trial as our seventh site! Pleased to be able to expand our coverage for this important trial of #GutMicrobiome manipulation with #IMT #FMT before #HCT; find out more here: www.imperial.ac.uk/metabolism-d... @imperialmdr.bsky.social

MAST study

The Imperial MAST study: Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) study.

www.imperial.ac.uk

1 1

Reposted by Ben Mullish

MAST Study @mast-study.bsky.social · Mar 19

Want to know more about why we are looking at the #GutMicrobiome #IMT #HCT as therapy? Find out even more here: youtu.be/zDd1qdVCa6A?...

youtu.be

1

Reposted by Ben Mullish

MAST Study @mast-study.bsky.social · Mar 19

The #MAST trial is pushing forward, investigating the impact of #IMT #FMT prior to #HCT in seven UK centres #HaemSky #MicrobiomeSky #GastroSky @imperialmdr.bsky.social @bloodcanceruk.bsky.social ruk.bsky.social @anthonynolan.bsky.social. Find out more from our poster or our website: rb.gy/myizsb

1 2 1

Reposted by Ben Mullish

medRxivpreprint @medrxivpreprint.bsky.social · Mar 13

The relationships between MASLD, extrahepatic multimorbidity and all-cause mortality in UK Biobank cohort https://www.medrxiv.org/content/10.1101/2025.03.09.25323328v1

1 1

Ben Mullish @bhmullish.bsky.social · Mar 6

A great first day at the #BSG #GutMicrobiome event, covering everything from early life @halllab.bsky.social, to #liver @debbieshawcross.bsky.social, to #cancer @jameskinross.bsky.social, and culminating in a tour de force on #IBD and the #microbiome in clinical practice from Prof Harry Sokol

1 1 7

Reposted by Ben Mullish

MAST Study @mast-study.bsky.social · Jan 22

MAST is moving onwards and upwards and now up to 18 recruited patients. We push on, hoping to see how gut #microbiome manipulation with #IMT #FMT can help our patients with #BloodCancer #HCT @bloodcanceruk.bsky.social @anthonynolan.bsky.social

1 2

Ben Mullish @bhmullish.bsky.social · Jan 7

Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social

FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial

Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...

doi.org

1 10 23

Ben Mullish @bhmullish.bsky.social · Dec 22

Great that the #MAST trial is moving ahead, and really hoping that this shows the #microbiome as a route to give new treatment prospects to #HCT #BloodCancer patients @bloodcanceruk.bsky.social @cancerresearchuk.org

MAST Study @mast-study.bsky.social · Dec 22

Now out - protocol paper for the #MAST trial, exploring #IMT #FMT to #prehabilitate the #GutMicrobiome in #BloodCancer patients receiving #HCT, now in #BMJOpen: doi.org/10.1136/bmjo... . Grateful to #MRC #DPFS for funding and #EnteroBiotix as project partners #HaemSky #MicrobiomeSky #GastroSky

3

Ben Mullish @bhmullish.bsky.social · Dec 14

Great work by Nabil Quraishi, Palak Trivedi and many others - unravelling the positive impact of #vancomycin in #PSC #IBD by altering interactions between the host, #microbiome, and #metabolome. Now in #JCC: academic.oup.com/ecco-jcc/adv... #GastroSky

Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures

AbstractBackground. We conducted a single-arm interventional study, to explore mucosal changes associated with clinical remission under oral vancomycin (OV

academic.oup.com

7 25

Ben Mullish @bhmullish.bsky.social · Dec 13

Great to work with the lab of @julieakmcdonald.bsky.social and see this preprint out on @biorxivpreprint.bsky.social, looking at how nutrient availability and microbial #metabolites impact #VRE colonisation in the #antibiotic treated gut: www.biorxiv.org/content/10.1... #MicroSky #GastroSky

2 7

Ben Mullish @bhmullish.bsky.social · Dec 7

Great work by Sharmili Balarajah with #ImperialMDR colleagues and the @nihr.bsky.social #IBD Bioresource team, now in press in #JCC - exploring differences in #IBD phenotypes and treatment approaches between White and South Asian patients in the UK: academic.oup.com/ecco-jcc/adv...

Diverse phenotypes, consistent treatment: a study of 30,997 South Asian and White IBD patients using the UK IBD BioResource

AbstractObjective. To evaluate South Asian (SA) and White (WH) inflammatory bowel disease (IBD) phenotypes, and to explore treatment approach variations be

academic.oup.com

2

Ben Mullish @bhmullish.bsky.social · Dec 6

Thanks to Gianluca Ianiro for co-ordinating the international consensus statement on #microbiome testing in clinical practice, now in Lancet GastroHep - an assessment of where we are and where we hope to go: doi.org/10.1016/S246... #GastroSky #MedSky

2 9

Ben Mullish @bhmullish.bsky.social · Dec 3

Unstoppable in the name of #AMR, even if it means being poisoned by The Thames - #microbiome manipulator extraordinaire, Prof Julian Marchesi @gut-health.bsky.social

gut-health.bsky.social @gut-health.bsky.social · Dec 3

Sampling at Erith Pier (London’s longest pier) to isolate bacterial viruses that kill antibiotic resistant bacteria. #antibioticresistance #esbl#ecoli#phage

2